Whey Protein and Adaptogenic Supplementation in Physically Active Females

May 12, 2026 updated by: Olivia Charlotte Coope, Sports Performance and Applied Research in Trials and Analysis

Whey Protein and Adaptogenic Herb Supplementation in Physically Active Females: A Randomised Controlled Trial

The goal of this clinical trial is to learn whether whey protein or plant protein supplements, with or without an adaptogenic herb blend, can improve strength, recovery, stress, and wellbeing in active females. The adaptogenic blend contains ashwagandha root extract and shatavari root extract.

The main questions the study aims to answer are:

Do whey protein and plant protein supplements improve muscle strength and recovery in physically active females? Does adding ashwagandha and shatavari improve stress, recovery, sleep, and wellbeing compared with protein alone? Are there differences between whey protein and plant protein when combined with the adaptogenic blend?

Researchers will compare four supplement groups:

Whey protein Whey protein with ashwagandha and shatavari Plant protein Plant protein with ashwagandha and shatavari

Participants will:

Take their assigned supplement daily for 6 weeks Attend testing sessions before and after the intervention Complete questionnaires about recovery, sleep, stress, soreness, and digestive health Provide saliva samples to measure stress, hormone, immune, and inflammation markers Complete muscle strength tests, including handgrip strength and push-up testing Complete a 24-hour dietary recall

The study includes physically active females aged 18 to 45 years who regularly participate in structured training.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • East Sussex
      • Brighton, East Sussex, United Kingdom
        • Recruiting
        • Strength and Nutrition Ltd
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Female, aged 18-45 years Currently participating in regular structured athletic or physical training (≥3 sessions per week) Free from musculoskeletal injury that would prevent testing Willing to maintain usual diet and training habits during the study Not currently using protein supplements or adaptogenic supplements

Exclusion Criteria:

Pregnant, breastfeeding, or planning pregnancy during the study period Known allergy or sensitivity to dairy, pea protein, pumpkin seed, chia seed, ashwagandha, shatavari, or nightshades Current use of prescribed medication that may interact with the supplements Thyroid disorders, autoimmune conditions, hormone-sensitive conditions, or other medical conditions that may be affected by supplementation Diagnosed eating disorder or condition affecting protein metabolism Current musculoskeletal injury preventing participation in testing Current use of other protein supplements or adaptogens

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Whey protein
Participants will consume a whey protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.
Participants will consume a whey protein supplement daily for 6 weeks. The supplement will be provided in identical blank sachets. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
Other Names:
  • Grass-Fed Whey Protein
  • Whey Protein Powder
Experimental: Whey Protein + Adaptogenic Blend
Participants will consume a whey protein supplement containing ashwagandha KSM-66® (250 mg) and shatavari SRI-81™ (300 mg) daily for 6 weeks. Assessments will be conducted at baseline and post-intervention.
Participants will consume a whey protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank sachets. Participants will maintain usual diet and training habits during the study.
Other Names:
  • Ashwagandha and Shatavari Whey Protein
  • Whey Protein Plus Adaptogens
Experimental: Plant protein
Participants will consume a plant-based protein supplement daily for 6 weeks. Assessments of muscle strength, recovery, stress, wellbeing, dietary intake, and salivary biomarkers will be conducted at baseline and post-intervention.
Participants will consume a plant-based protein supplement daily for 6 weeks. The supplement will be provided in identical blank sachets. Participants will be instructed to maintain their usual diet and training habits throughout the intervention period.
Other Names:
  • Plant-Based Protein
  • Vegan Protein Supplement
Experimental: Plant Protein + Adaptogenic Blend
Participants will consume a plant-based protein supplement containing ashwagandha KSM-66® (250 mg) and shatavari SRI-81™ (300 mg) daily for 6 weeks. Assessments will be conducted at baseline and post-intervention.
Participants will consume a plant-based protein supplement containing ashwagandha KSM-66® root extract (250 mg) and shatavari SRI-81™ root extract (300 mg) daily for 6 weeks. Supplements will be provided in identical blank sachets. Participants will maintain usual diet and training habits during the study.
Other Names:
  • Plant Protein Plus Adaptogens
  • Ashwagandha and Shatavari Plant Protein

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Salivary Cortisol Concentration
Time Frame: Baseline and Week 6
Change in salivary cortisol concentration from baseline to post-intervention following 6 weeks of whey protein or plant protein supplementation with or without an adaptogenic herb blend containing ashwagandha KSM-66® and shatavari SRI-81™.
Baseline and Week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handgrip Strength
Time Frame: Baseline and Week 6
Change in maximal handgrip strength measured using a CAMRY dynamometer from baseline to post-intervention.
Baseline and Week 6
Upper Body Muscular Endurance
Time Frame: Baseline and Week 6
Change in upper body muscular endurance assessed using the 90-degree push-up test protocol from baseline to post-intervention.
Baseline and Week 6
Perceived Recovery and Wellbeing
Time Frame: Baseline and Week 6
Change in perceived sleep quality, fatigue, muscle soreness, stress, and recovery measured using the Hooper Index questionnaire.
Baseline and Week 6
Salivary Biomarkers of Stress, Hormonal Status, Immunity, and Inflammation
Time Frame: Baseline and Week 6
Changes in salivary DHEA-S, oestradiol, secretory immunoglobulin A (sIgA), interleukin-6 (IL-6), and interleukin-1 beta (IL-1β) concentrations from baseline to post-intervention.
Baseline and Week 6
Perceived Gastrointestinal Health
Time Frame: Baseline and Week 6
Change in gastrointestinal symptoms and digestive comfort assessed using a gastrointestinal distress questionnaire.
Baseline and Week 6
Dietary Intake
Time Frame: Baseline and Week 6
Dietary intake assessed using a 24-hour dietary recall to evaluate habitual nutritional intake during the study period.
Baseline and Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

August 12, 2026

Study Completion (Estimated)

September 20, 2026

Study Registration Dates

First Submitted

May 12, 2026

First Submitted That Met QC Criteria

May 12, 2026

First Posted (Actual)

May 18, 2026

Study Record Updates

Last Update Posted (Actual)

May 18, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data (IPD) will not be shared with other researchers. Data collected in this study will be anonymised and retained only for the duration of analysis before permanent deletion, in accordance with the study protocol, participant consent, and UK GDPR requirements.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Recovery

Clinical Trials on Whey protein

Subscribe